Since FAM136A possibly involves a variety of biological functions of lung carcinoma cells as described in this section, residual carcinoma cells following surgical treatment in FAM136A- positive lung carcinomas could still have the potential to recur despite the adjuvant therapies rapidly. Here, TIMCC is linked to lung carcinoma.